A case of severe autoimmune hepatitis triggered by discontining long term Celestamine treatment
-
- Noritake Hidenao
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Kageyama Fujito
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Takehira Yasunori
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Yamada Masami
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Murohisa Go
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Kataoka Hideki
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Sano Munetaka
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Iwaoka Yasushi
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Takahashi Yurimi
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Ikeya Manae
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Terai Tomohiro
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Watanabe Shinya
- Department of Gastroenterology, Hamamatsu Medical Center
-
- Ozawa Takachika
- Department of Pathology, Hamamatsu Medical Center
-
- Yasumi Kazuhiko
- Department of Pathology, Hamamatsu Medical Center
-
- Kobayashi Yoshimasa
- Second Department of Internal Medicine, Hamamatsu University School of Medicine
Bibliographic Information
- Other Title
-
- セレスタミンを長期内服し休薬後に重症自己免疫性肝炎を発症した1例
- 症例報告 セレスタミンを長期内服し休薬後に重症自己免疫性肝炎を発症した1例
- ショウレイ ホウコク セレスタミン オ チョウキ ナイフク シ キュウヤク ゴ ニ ジュウショウ ジコ メンエキセイ カンエン オ ハッショウ シタ 1レイ
Search this article
Abstract
The patient was a 70-year-old man. He had been treated with Celestamine® about three years for his chronic sinusitis. He was admitted to our hospital for his clinical symptoms including nausea, pruritus, and yellow urine. We diagnosed autoimmune hepatitis from the examinations and clinical course. At first, we treated him with UDCA (600mg/day). His general condition was not well for several days, so we then treated him with PSL (30mg/day), where upon he improved. The pathological findings showed inflammation cell permeation and rosette formation. It was thought that his discontinuation of Celestamine® triggered deterioration resulting in serious autoimmune hepatitis. Moreover, much remains unclear as to the implications of the excess iron deposits in liver tissue in terms of autoimmune hepatitis. Thus, further investigations are necessary in this regard.<br>
Journal
-
- Kanzo
-
Kanzo 47 (7), 341-346, 2006
The Japan Society of Hepatology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204790933760
-
- NII Article ID
- 10018264653
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL BIB ID
- 7991007
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed